Search results for: “keytruda”
-
Blog
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
Blog
FDA approves Keytruda combo for first-line lung cancer treatment
Patients in the U.S. who have advanced nonsquamous non-small cell lung cancer can now receive Keytruda as…
-
Blog
Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer
Anti-PD-1 checkpoint antibody is the only immunotherapy approved for first-line treatment for lung cancer patients.
-
Blog
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
Blog
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma
The decision makes pembrolizumab the second PD-1-blocking drug to receive approval in Europe.
-
Page
A Patient’s Guide to Immunotherapy for Breast Cancer
A Patient’s Guide to Cancer Immunotherapy Breast Cancer What You Need to Know Hearing the words “You… -
Page
A Patient’s Guide to Immunotherapy for Ovarian Cancer
A Patient’s Guide to Cancer Immunotherapy Ovarian Cancer What You Need to Know Hearing the words “You… -
Blog
A New Milestone for Cancer Vaccines — Decades in the Making
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a patient’s immune… -
Blog
What Patients Should Know About Sarcoma and Immunotherapy
Sarcoma is rare and complex. Immunotherapy isn’t yet an option for everyone — but it’s changing what’s…